BOPI 09 BR/2023 REPERTOIRE NUMERIQUE 36 Fig. 1 Consulter le mémoire ________________________________________ (11) 21171 (51) A61K 31/567 (2018.01); A61K 9/20 (2018.01); A61K 9/28 (2018.01) ; A61P 15/18 (2018.01) (21) 1202300050 - PCT/EP2021/072584 (22) 13/08/2021 (30) EP n° 20382753.0 du 14/08/2020 (54) New modified release oral contraceptive composition. (72) COLLI, Enrico (ES) (73) CHEMO RESEARCH, S.L., C/ Manuel Pombo Angulo 28, 3° planta, 28050 MADRID (ES) (74) S.C.P AKKUM, AKKUM & Associates, n° 1777, Rue 6.261, Auditorium Jean Paul II, Quartier Mbankolo, B.P. 4966, YAOUNDE (CM). (57) The invention relates to a new modified release oral pharmaceutical form comprising 17αcyanomethyl-17-β-hydroxyestra-4,9-dien-3-one (dienogest) and 17α-ethinylestradiol (ethynyl estradiol), its method of production and its medical and non-medical uses, in particular its use in contraception. Fig. 5 Consulter le mémoire ________________________________________ (11) 21172 (51) A01N 25/02 (2018.01); A01N 25/30 (2018.01);
RkJQdWJsaXNoZXIy MTM1NDc3MA==